A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma
Clinical trial NCT04121260 · COMPLETED
Trial details
- NCT number
- NCT04121260
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-25
- Primary completion
- 2021-04-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.